Bristows
Expertise
Core sectors
Life sciences
Technology
Brands
Litigation
Patent litigation
Brands, designs & copyright
Commercial & technology disputes
Competition litigation
Data breaches & cyber security
SEP/FRAND disputes
Media disputes
IT disputes
Transactions
Corporate & financing
IT & digital
Commercial & IP transactions
Employment
EU & UK merger control
Real estate
Tax
Regulatory & advisory
Competition advice & investigations
Data protection & privacy
Life sciences regulatory
TM & design portfolio management
Freedom to operate
Advertising & marketing
Charities & not-for-profit
Viewpoint
Articles
News
Publications
Events
Inquisitive minds
People
Careers
Trainees
Current opportunities
Inclusion and Diversity
Life at Bristows
About us
Our values
A reputation for firsts
International reach
Awards
Corporate responsibility
Alumni
Compliance information
GDPR
Contact
toggle mobile menu
Home
On the Pulse
On the Pulse
Latest News
VIEW:
All topics
Brexit
Healthtech
Copyright
Artificial Intelligence
UPC
Trade marks
Digital Single Market
Gene editing
Patents
Licensing
Employment / employers
COVID-19
Open Technology
FRAND
Robotics and AI
Interactive entertainment
All sectors
Life sciences
Technology
Brands
All practices
Commercial & technology disputes
Brands, designs & copyright
TM & design portfolio management
Competition
Patent litigation
Life sciences regulatory
IT & digital
Data protection & privacy
Real estate
Corporate & financing
Employment
Tax
Charities & not-for-profit
Advertising & marketing
Data breaches & cyber security
Competition advice & investigations
EU & UK merger control
Judicial review
Commercial & IP transactions
Freedom to operate
SEP/FRAND disputes
Brexit
Media disputes
COVID-19
IT disputes
Arbitration
Confidential information & trade secrets
Life sciences: contract & product liability disputes
All dates
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
May 2013
Advertising medicines and medical devices in the UK: Who’s who?
05.11.2021
What’s the wait? – Number of MDR and IVDR notified bodies remains stubbornly low
01.11.2021
Spotlight on mRNA – Regulation of mRNA vaccines and therapies
28.10.2021
EC proposals for Northern Ireland: A way forward for medicines?
22.10.2021
Spotlight on mRNA – Recent deal activity
21.10.2021
Going live – New rules on publication of clinical trials results-related information under the EU Clinical Trials Regulation
13.10.2021
What’s new in the future UK regulation of medical devices?
13.10.2021
Webinar Bristows reacts: the future regulation of medical devices in the UK
12.10.2021
Spotlight on mRNA – IP landscape
08.10.2021
View more
